Why the study?
Do MR-proANP levels predict disease severity and survival in patients with lower respiratory tract infections?
Do MR-proANP levels predict disease severity and survival in patients with lower respiratory tract infections?
MR-proANP levels are elevated in lower respiratory tract infections and may assist in risk stratification and predicting survival, particularly in community-acquired pneumonia.
No takes yet. Share an insight, caveat, or question.
Elevated MR-proANP was associated with mortality in CAP; hypothesis-generating for risk stratification and requires prospective validation.
Müller‐Stich et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: